ANZGOG’s Annual Scientific Meeting
The ANZGOG Annual Scientific Meeting (ASM) is the premier gathering for the gynaecological oncology community across Australia and New Zealand.
Held annually, the ASM brings together national and international experts in gynaecological medicine, radiation oncology, surgical oncology, pathology, research, study coordination and nursing, alongside lived experience advocates and partners from the pharmaceutical industry. Together, they share the latest advances in gynaecological cancer research and foster the collaborations that drive the field forward.
The three-day event attracts close to 400 delegates, making it one of the largest gatherings of the gynaecological oncology community across Australia and New Zealand. It provides an opportunity to learn about the latest developments in gynaecological cancer while fostering education, collaboration, networking and capacity-building among ANZGOG members and industry partners.
A highlight of the program is the Pure Science Symposium, which offers a dedicated forum for scientists and clinicians to discuss emerging pre-clinical and translational research.
Where leaders come together to drive progress
The ANZGOG 2026 Annual Scientific Meeting brought together more than 300 delegates at the Gold Coast Convention and Exhibition Centre from 25 to 27 March, under the theme On the Edge: Translating Innovation into Action.
The three-day program showcased the latest in gynaecological cancer research, from AI and rare cancers to the next generation of clinical priorities, and celebrated the 2026 Recognition Award recipients for their outstanding contributions to the field.
SAVE THE DATE – ANZGOG 2027 ASM
📍 Adelaide, SA
📅 21–23 April 2027
After a record-breaking 2026 Annual Scientific Meeting (ASM), we are excited to look ahead to ANZGOG 2027.
Join us in Adelaide from 21–23 April 2027, where ANZ and international gynaecological cancer community will come together to connect, collaborate, and shape the future of research, treatment and care.
Timed to coincide with a long weekend and school holiday period, the 2027 ASM offers an ideal opportunity to extend your stay and experience all that South Australia has to offer.
Save the date and be part of the conversations, discoveries and collaborations driving the next generation of progress in gynaecological cancer.
More details to be released soon.
For all sponsorship enquiries, please contact Karen Livingstone AM via email: karen.livingstone@anzgog.org.au
Meeting the 2026 ASM International Speakers
Professor Woo Yin Ling
Gynaecological Oncologist, Malaysia
Professor Woo Yin Ling is a Professor of Obstetrics and Gynaecology at the University of Malaya and a Consultant Gynaecological Oncologist at University Malaya Medical Centre. Her work focuses on the screening, prevention, and management of gynaecological cancers, with a strong emphasis on solutions tailored to the Malaysian context.
Professor Woo is a strong advocate for healthcare innovations that are locally relevant and community-informed—particularly those that centre the voices of women.
Her contributions have been recognised internationally, including the FIGO Award in 2021 and the Rachel Pearline Award in 2022, for her work in advancing gynaecological cancer care in low- and middle-income countries.
She currently serves as Malaysia’s country representative to AOGIN, is a member of the WHO Screening and Treatment Working Group, the APEC and Commonwealth Cervical Cancer Working Group.
Professor Woo is also a founding trustee of the ROSE Foundation, an initiative aimed at eliminating cervical cancer through community-empowered, evidence-based solutions.
Dr Kathleen Moore
Gynaecological Oncologist (Medical Oncology Keynote), USA
Dr Kathleen Moore is the Associate Director of Clinical Research, Stephenson Cancer Center and Director, Oklahoma TSET Phase I Program. She is board certified in obstetrics and gynaecology as well as gynaecologic oncology and hospice and palliative care.
Dr. Moore has published more than 200 peer-reviewed publications and serves on the editorial board for four academic publications. She has a clinical research interest in drug development and phase I trials.
She is the Designated Surgical Oncologist on the ASCO Board of Directors, as well as a member of ASCO’s Cancer Communications Committee.
Dr William Small
Radiation Oncologist, USA
William Small, Jr., MD, FACRO, FACR, FASTRO, is Professor and Chair of the Department of Radiation Oncology and Director of the Cardinal Bernardin Cancer Center at Loyola University Chicago, and Vice President of Oncology for the Trinity Health IL/IN Division.
Dr. Small completed medical school and residency training at Northwestern University School of Medicine. He has been an active researcher, teacher, and clinician for more than 30 years and has an international reputation for research and treatment of gynecological malignancies, gastrointestinal and breast cancers.
Dr. Small is a fellow of the American College of Radiation Oncology, the American College of Radiology, and the American Society for Radiation Oncology. He is a past president of the Gynecologic Cancer InterGroup and holds leadership positions in many professional organizations including the American College of Radiation Oncology, the International Commission for Radiological Protection, and the American Radium Society,
He is the author of over 330 publications, 38 invited book chapters, and 7 books.
